// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

The endobronchial ultrasound features of malignancy

Hannah Yeo - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

mHealth mood monitoring for people with COPD

Maxine Whelan - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Anxiety

N/A

Digitalising the personalised asthma action plan (PAAP) - a multi-perspective qualitative study

Uddhav Vaghela - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

myAirCoach: mHealth assisted self-management in patients with uncontrolled asthma, a randomized control trial

Rishi Khusial - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Asthma innovation landscape: The Asthma Lab pilot programme

Brigitte West - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Digital Therapy in the treatment of asthma and COPD - Epidemiology of development and use of an emerging health technology in Respiratory Medicine

Roberta Bodini - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Asthma

Methadone hydrochloride

Virtual clinic for following up children with long term ventilation and complex respiratory needs

Molla Imaduddin Ahmed - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Adherence in patients with COPD and heart failure using an eHealth self-management intervention

Mirthe Bakker - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Congestive heart failure

N/A

Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study

Syed Ahmar Shah - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Are mobile device applications effective at supporting COPD self-management compared to usual care?

George Shaw - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease

Declan Doherty - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis

Mary Mcelroy - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nintedanib

Hypoxia-inducible factor pathway activation promotes bone-type collagen cross-linking in Idiopathic Pulmonary Fibrosis

Christopher J Brereton - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Use of Telemetry and Plethysmography to Assess Respiratory Function in Conscious Rats with Bleomycin-Induced Lung Fibrosis

Mary Mcelroy - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Bleomycin

TGFß1 induces collagen deposition and increased tissue stiffness in sarcoidosis fibroblasts grown in a novel, long term, 3D culture system

Mark Ward - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Pulmonary fibrosis

N/A

Preclinical data using a novel porcupine inhibitor demonstrates that inhibition of porcupine is a promising target for the treatment of Idiopathic Pulmonary Fibrosis

Peter Bunyard - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Bleomycin

We are not an island - initiating a respiratory trainee research network

Alexandra Dipper - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Improving the standard of practical pleural procedures teaching for junior doctors: A quality improvement project

Junyi Zhang - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Do UK postgraduate medical trainees prefer to do mentor supported respiratory quality improvement projects compared to traditional audit?

Aklak Choudhury - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Lowering the p value threshold in recently published Respiratory Medicine RCTs

Akanksha Malhotra - European Respiratory Society (ERS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Methadone hydrochloride

Copyright © 2026. QuantiNova All rights reserved